FairScope Lab
EN 繁中 简中

JNJ

Valuation Healthcare · Drug Manufacturers - General Data as of 2025-12-31

P/E Ratio · Metrics

P/E Ratio

24.67

PEG Ratio

0.29

Dividend Yield

-

Gross Margin

86.37%

Net Margin

20.83%

Revenue CAGR 3Y

1.19%

ROE

25.10%

ROA

10.27%

Buyback Yield

-0.43%

Current Ratio

1.03

Magic Earn Yield

3.33%

Altman Z-Score

3.97

Fair Value River

Score

Valuation 54
Profitability 55
Growth 4
Health 57
Yield 0
← Back to Dashboard